Medical Learning Hub (MLH) welcomes you to recorded live clinical experience sharing on Topic: "Contrasting RWE of Remdesivir to Solidarity, and managing Pulmonary comorbidity. Is there a need to change practice?"
What was covered:
Module 1: (00:00:00-00:05:42) Introduction and Poll: Medical Learning Hub team welcomed all the panelists and participants and raised the poll. Then the panelists were introduced and the structure of the webinar with general instructions were shared with the participants.
Module 2: (00:06:52-00:44:59) Pulmonary Comorbidities in COVID patients: Dr. Nandagopal Velayuthaswamy MD, Consultant Pulmonologist, Institute of Lung Care & Research Hindustan Hospital, Coimbatore started the session by discussing on pulmonary comorbidities. He explained about chronic pulmonary diseases, like Asthma, COPD, ICD, Thoracic cancer, Sleep apnea, Obesity and their relationship with COVID-19. Dr Nandagopal explained the do’sand don’t for patient, precautions to be taken and necessary required investigation for the case.
Module 3: (00:45:17-01:03:20) Clinical Studies & Current experience on Remdesivir- Is there a need to change our practice? Dr. M.N.Sivakumar, Head - Institute of Critical Care Medicine, Royal Care Super Speciality Hospital, Coimbatore, continued the session by explaining about the pharmacological treatment for COVID disease. He explained in detail about Remdesivir, purpose of therapy in mild, moderate and severe disease. Dr Siva Kumar also shared their hospital experiences in treating COVID patients with the use of Remdesivir, its effects, contraindication, and adverse effects.
Module 4: (01:03:34-01:22:30) Question and Answer: Several questions were received during the session, which were answered by the speakers at the end of the session
Module 5: (01: 22: 30-01: 24: 26) Poll and Thank you note: At the end poll was raised and thank you note was shared by the Medical Learning Hub team with panelists, participants and Viatris to make this program possible.
We thank our sponsors Viatris to make this program possible and we wish you a great learning experience.
Thank you for showing interest in Contrasting RWE of Remdesivir to Solidarity, and managing Pulmonary comorbidity. Is there a need to change practice?. We are sorry that the course is unavailable at the moment. Please leave your contact details and we will notify you of related courses or upcoming dates.